Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection-Reference-Cited by-同舟云学术

Decreased Seroreactivity in Individuals Initiating Antiretroviral Therapy during Acute HIV Infection

Published:2019-10 Issue:10 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Manak Mark M.¹^ORCID,Jagodzinski Linda L.²,Shutt Ashley¹,Malia Jennifer A.²,Leos Mike³,Ouellette Jason¹,Akapirat Siriwat⁴,Colby Donn L.⁵,Phanuphak Nittaya⁵,Eller Leigh Anne¹,Robb Merlin L.¹,de Souza Mark⁵,Ananworanich Jintanat¹⁵,Peel Sheila A.²

Affiliation:

1. U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA

2. U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA

3. Bio-Rad Laboratories, Inc., Benicia, California, USA

4. Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand

5. SEARCH, Thai Red Cross AIDS Research Centre, Bangkok, Thailand

Abstract

Antiretroviral therapy (ART) during acute HIV infection (AHI) interrupts viral dynamics and may delay the emergence of serological markers targeted by current HIV screening and confirmatory assays, thus creating challenges for correctly classifying HIV infection status.

Funder

U.S. Department of Defense

DOD | United States Army | MEDCOM | Walter Reed Army Institute of Research

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00757-19

Reference54 articles.

1. Prevention of HIV-1 Infection with Early Antiretroviral Therapy